The Burke Medical Research Institute and Blythedale Children”™s Hospital, a specialty children”™s hospital in Valhalla, have created a research partnership that will allow advances made at Burke”™s labs to translate into improved treatments for children with neurological impairments at Blythedale.
The collaboration between the two organizations aims to improve patients”™ movement, vision and cognition impairments caused by strokes, traumatic brain injuries, cerebral palsy, birth defects and other neurological conditions. Â
“This isn”™t just a marriage, it”™s a marriage made in heaven,” said Blythedale board chair David Pedowitz. “With (Burke’s)Â expertise in brain repair, and Blythedale”™s expertise in the care of medically fragile children, we are poised to make great advances in science and clinical care.”
The collaboration is directed by Jason Carmel, a pediatric neurologist and neuroscientist.
“We don”™t know enough about how injury affects the developing brain,” said Burke board chair Robert Baldoni. “This partnership offers a unique opportunity to accelerate the scientific discoveries and clinical advances that these children desperately need.”
Blythedale President and CEO Larry Levine said the cutting-edge research at Burke is “critical to bringing the next generation of therapies to children with neurological disabilities.”
White Plains-based Burke was founded in 1978 and is composed of more than 100 researchers in 18 laboratories and over 20,000 feet of laboratory space. Â Â
